00000nam 2200000zi 4500 9.884270 CaOODSP 20221107170823 m o d f cr ||||||||||| 200204t20202020oncd ob f000 0 eng d 9780660339382 CaOODSP eng rda CaOODSP n-cn--- H14-344/2020E-PDF Leigh-Bennett, Richard, author. Assessment of Health Canada's communications to external stakeholders on marketed health products : qualitative research : final report / submitted by: Richard Leigh-Bennett ; prepared for: Health Canada. Marketed health products communications research report Ottawa, Ontario : Health Canada = Santé Canada, 2020. ©2020 1 online resource (42 pages) : graphs + 1 executive summary (6 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Title from cover. "February 19, 2020." Issued also in HTML format. "Supplier name: Pollara Strategic Insights." "Contract Number: HT372-184553/001/CY." "POR Registration number: 136-18." "Health Canada POR Number: 18-25." Issued also in French under title: Évaluation des communications de Santé Canada aux intervenants externes à propos des produits de santé commercialisés : recherche qualitative : rapport final. Includes references. "Health product safety in Canada is a shared responsibility. Many different organizations and individuals, including Health Canada, health care professionals, manufacturers, consumers and others, have a role to play in the effective and timely communication of health product safety information. As part of its role, Health Canada develops a wide range of products designed to communicate externally to key stakeholders (including the public) on issues related to health product safety, including, but not limited to: guidance documents; risk communications; health product safety information; and, communications around transparency"--Background and objectives, page 8. Health products Government policy Canada Public opinion. Health risk communication Government policy Canada Public opinion. Public opinion Canada. Canada. Health Canada. Pollara Strategic Insights. Évaluation des communications de Santé Canada aux intervenants externes à propos des produits de santé commercialisés : (CaOODSP)9.884271 PDF 1,021 KB https://publications.gc.ca/collections/collection_2020/sc-hc/H14-344-2020-eng.pdf Final report PDF 487 KB https://publications.gc.ca/collections/collection_2020/sc-hc/H14-344-2020-1-eng.pdf Executive summary HTML N/A https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/136-18-e/mhpd-e.html Final report HTML N/A https://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/136-18-e/summary/summary.html Executive summary